Caladrius Biosciences Strikes Deal With Japanese Regulators On Development Plan For Cell Therapy

By: via Benzinga
Caladrius Biosciences Inc (NASDAQ: CLBS) disclosed that it struck a deal with the Japanese Pharmaceutical and Medical Devices Agency ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.